
Keywords: OCT، حمل و نقل کاتیونی آلی; BCRP, breast cancer related protein; CML, chronic myeloid leukemia; IMA, Imatinib; P-gP, P-glycoprotein; OCT, organic cation transporter; TKI, tirosine kinase inhibitorCML; Imatinib resistance; Therapeutic interruptions; Membrane drug transporters; P-glyc